The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Plus the Royalty agreement could be another £5 million. So long term looking good . Gla
Surely a positive sign, why would CIZ sign up for a royalty agreement with SGS for AZD it's further applications as well as other treatments unless it felt there was potential here.
No idea how long it will take, Vela won't disclose anything via email, would only say they will share what they can when they can subject to SGS news. For me DYOR, ignore the noise and the trolls.
ATB
https://www.lse.co.uk/rns/CIZ/agreement-with-st-george-street-capital-fy4r14cys1a4wzn.html
The relevant CIZ RNS regarding SGS and AZD1656
TR1 issued for CIZ who also have a deal with SGS. It was not Vela buying in, question is whether this could be a bullish sign.
Have I missed something re Ciz on Vela buying in?
large holding taken in ciz,
is this a possible sign?
ciz have a investment in our trial , via sgsc.
It was a little tongue in cheek but agree, I would like to see more investments like Aeristech with long lead time to IPO or SGS trial which us investors don't normally get a sight of. I believe that is where the true value could lie with this sort of company. The other investments are made just as companies IPO and we could easily have invested ourselves directly at IPO price or as it turns out, even lower in some cases.
You say that BD and it's a good idea although personally I'm hoping that it's earmarked to increase the Airestech stake if not already spoken for behind the scenes re: Arcadia follow up.
Best use of funds would be share buyback 4bn @ 0.05 alongside Management taking equity in lieu of fees to conserve cash til investments show a decent return.
Some of the cash went on SKL and perhaps the rest is earmarked for a further investment in Excalibur/igraine/SGS
tempting to add at 0.0474
That's a fair assessment TH. I'm also half full but it's opinion. CSFS should recover over time, MODE shot themselves in the foot (twice) and are going to need something big to get them back in the game. The real oddity is the cash in the bank, we all want to know the reasoning behind that.
Its like any share, 2 vastly different point of views:
The positives - VELA has gone from loss making to profit in the last financial year and now debt free with a healthy bank balance*, Some really positive investments (CODE and KNB) with hopefully another belter in Aeristech. Invested in a Covid drug trial which could be explosive*
Negatives - Lack of communication, Sat on funds for extended periods of time (we are an investment company, no good money sat doing nothing), Some investments performing appallingly (MODE & CSFS), Invested in a Covid drug trial which could make a £2.35M hole in the accounts*
Depends how you see your glass, half full or half empty. For now, mine is definitely half full and I am very envious of investors getting in at these prices. Some will say this price is too expensive (MG).
Ah I thought you were saying "oh no it isnt (the bottom)", my mistake.
I did qualify that I was wrong
Twisty, mine is the 20.4m buy, so not sure what you're referring to?
Well I did pile a load into what I thought was the ultimate bottom Nelson, so I guess I have to be satisfied with that. Even if there are other bottoms.
Like an impaired vision person at an orgy that bottom can be elusive to find, it may look like the bottom and feel like the bottom, but is it the ultimate bottom or just one of the many others!
oh, no it isn't, not that it matters. Still hoping this is the bottom.
hit today, and so far mine is the biggest trade of the day. Let's hope we've found the bottom.